Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: Long-term results of endoscopic treatment

Background and study aims This longitudinal prospective study evaluated the long-term outcome of endoscopic treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectases (HHT), its safety and outcome predictors. Patients and methods Consecutive patients with HHT and either anemia d...

Full description

Saved in:
Bibliographic Details
Published in:Endoscopy International Open 2023-12, Vol.11 (12), p.E1145-E1152
Main Authors: Manfredi, Guido, Crinò, Stefano Francesco, Alicante, Saverio, Romeo, Samanta, Berté, Roberto, Gandolfi, Silvia, Spinazzola, Angelo, Fiini, Michela, Forner, Pierangelo, Buscarini, Elisabetta
Format: Article
Language:English
Subjects:
RFA and ablative methods
Small bowel endoscopy
Small intestinal bleeding
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and study aims This longitudinal prospective study evaluated the long-term outcome of endoscopic treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectases (HHT), its safety and outcome predictors. Patients and methods Consecutive patients with HHT and either anemia disproportionate to epistaxis or overt gastrointestinal bleeding received endoscopic treatment of gastrointestinal telangiectases with argon plasma coagulation (APC). Hemoglobin levels and transfusion requirements were evaluated before and after treatment. Treatment effectiveness was classified as: 1) complete: hemoglobin level during the follow-up ≥9 g/dL; 2) complete with recurrence: hemoglobin ≥9 g/dL for at least 12 months with subsequent drop to
ISSN:2364-3722
2196-9736
DOI:10.1055/a-2190-9303